Folic Acid Supplementation During Pregnancy: Unraveling the U-Shaped Relationship with Congenital Heart Disease and Solutions

Learn More

Navigating Folate Intake: Safeguarding Against Gestational Diabete

Learn More

Gestational Diabetes Risk and Folate Supplementation: Opting for Folic Acid or 6S-5-Methyltetrahydrofolate?

excessive synthetic folic acid intake could lead to the accumulation of unmetabolized folic acid (UMFA) in the blood, potentially increasing the risk of gestational diabetes.Magnafolate, participates in homocysteine metabolism, helping to lower homocysteine levels and prevent cardiovascular diseases.

Learn More

Research Report: The Relationship Between HCY, MTHFR, Oxidative Stress, and Gestational Hypertension and Preeclampsia

Studies have shown that plasma homocysteine (HCY), 5,10-methylenetetrahydrofolate reductase (MTHFR), and oxidative stress are associated with the occurrence of gestational hypertension and preeclampsia.

Learn More

The Impact of 6S-5-Methyltetrahydrofolate on Endothelial Cell Function During Pregnancy and Its Potential in the Treatment of Gestational Hypertension

By elevating BH4 levels, 6S-5-methyltetrahydrofolate may enhance the ability of endothelial cells to produce nitric oxide, thereby aiding in vasodilation, lowering blood pressure and the risk of Gestational Hypertension, and safeguarding the health of both mothers and fetuses.

Learn More

Research Report: The Association Between Folic Acid Supplementation and the Risk of Gestational Hypertension

Learn More